Evidence map›Paper›PMID 27324886›Full record

ArticleJournal of clinical immunology2016

X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.

Joel Gallagher, Juan Adams, Mary Hintermeyer, Troy R Torgerson, Jesus Lopez-Guisa, Hans D Ochs, Sara Szabo, Mina Salib, James Verbsky, John Routes

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Pulmonary alveolar proteinosis andFrontiers in pediatrics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Pulmonary alveolarproteinosis in children.Breathe (Sheffield, England) · 2020
    Review
  6. Pulmonary Alveolar Proteinosis Due toFrontiers in pediatrics · 2020
    Article
  7. Article
  8. Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Joel GallagherDivision of Asthma, Department of Pediatrics, Allergy and Clinical Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Juan AdamsDivision of Asthma, Department of Pediatrics, Allergy and Clinical Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Mary HintermeyerDivision of Asthma, Department of Pediatrics, Allergy and Clinical Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Troy R TorgersonDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, WA, USA.
Jesus Lopez-GuisaDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, WA, USA.
Hans D OchsDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, WA, USA.
Sara SzaboDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Mina SalibDivision of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
James VerbskyDivision of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
John RoutesDivision of Asthma, Department of Pediatrics, Allergy and Clinical Immunology, Medical College of Wisconsin, Milwaukee, WI, USA. jroutes@mcw.edu.
Medical College of Wisconsin · USSeattle Children's Hospital · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeX-linked hyper IgM syndrome (XHIGM) is a combined immunodeficiency caused by mutations in the CD40 ligand (CD40L) gene that typically results in decreased or absent CD40L expression on activated T cells, leading to defective class switching and somatic hypermutation. We describe an infant who presented with respiratory failure due to pulmonary alveolar proteinosis (PAP) with a novel damaging missense mutation in the CD40L gene.

methodsWhole exome sequencing (WES) was used to identify a mutation in the CD40L gene. CD40L expression and function were determined by flow cytometry.

resultsA 5-month-old previously-healthy male presented with respiratory failure and diffuse pulmonary ground glass opacities on CT scan of the chest. Laboratory evaluation revealed an undetectable IgG, normal IgA, and elevated IgM. A bronchoalveolar lavage demonstrated pulmonary alveolar proteinosis. WES demonstrated a c.608G > C mutation in the CD40L gene resulting in p.R203T. Flow cytometry demonstrated normal CD40L expression on activated T cells but absent binding of CD40-Ig to CD40L on activated patient T cells.

conclusionsThe clinical manifestations of XHIGM in our patient had several unique features, including the presentation with PAP, normal serum IgA, and expression of non-functional CD40L on activated T cells. To our knowledge, this is the first published case of PAP in a patient with XHIGM.

Indexed as

PhenotypeBiomarkersCD40 LigandDiagnosis, DifferentialExome SequencingHumansHyper-IgM Immunodeficiency Syndrome, Type 1InfantLymphocyte ActivationLymphocyte CountLymphocyte SubsetsMaleMutationPulmonary Alveolar ProteinosisRadiography, ThoracicTomography, X-Ray ComputedBiomarkersCD40 LigandCD40 ligand (CD40L)Hyper IgM SyndromeMacrophage dysfunctionPulmonary alveolar proteinosis

Identifiers

PMID27324886
OpenAlexW2461224675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.